Scott, Mark

Selected Publications
  1. Kyluik-Price DL, Li L, Scott MD: Effects of Methoxypoly (Ethylene Glycol) Mediated Immunocamouflage on Leukocyte Surface Marker Detection, Cell Conjugation, Activation and Alloproliferation.  Biomaterials 2016; 74:167-177.
  2. Li L, Noumsi GT, Kwok YYE, Moulds JM, Scott MD: Inhibition of Phagocytic Recognition of Anti-D Opsonized Rh D+ RBC By Polymer-Mediated Immunocamouflage.  American Journal of Hematology, 2015; 90:1165-1170.
  3. Scott MD: ResearchUnit: Using immunocamouflage to fool the immune system. 2015; Transfusionmedicince.ca website.
  4. Kyluik-Price DL, Li L, Scott MD: Comparative efficacy of blood cell immunocamouflage by membrane grafting of methoxypoly(ethylene glycol) and polyethyloxazoline. Biomaterials 2014; 35:412-422.
  5. Wang D, Toyofuku WM, Scott MD: The potential utility of methoxypoly(ethylene glycol)-mediated prevention of Rhesus blood group antigen RhD recognition in transfusion medicine.  Biomaterials 2012; 33:3002-3012.
  6. Wang D, Toyofuku WM, Chen AM, Scott MD: Induction of immunotolerance via mPEG grafting to allogeneic leukocytes. Biomaterials 2011; 32:9494-9503.
  7. Scott MD, Murad KL, Koumpouras F, Talbot M, Eaton JW: Chemical camouflage of antigenic determinants:  “Stealth” erythrocytes.  Proc. Nat. Acad. Sci. USA 1997; 94:7566-7571.
Selected Publications
  1. Kyluik DL, Sutton TC, Le Y, Scott MD: Chapter 7: Polymer-mediated broad spectrum antiviral prophylaxis: utility in high risk environments. In: Progress in Molecular and Environmental Bioengineering - From Analysis and Modeling to Technology Applications (Editor: Carpi A.) Intech, ISBN 978-953-307-268-5. 2011; pp.167-190.
  2. Sutton TC, Scott MD: The effect of methoxypoly(ethylene glycol) chain length on the inhibition of respiratory syncytial virus (RSV) infection and proliferation.  Biomaterials 2010; 31:4223-4230.
  3. McCoy LL and Scott MD: Broad spectrum antiviral prophylaxis: Inhibition of viral infection by polymer grafting with methoxypoly(ethylene glycol). In: Antiviral Drug Discovery for Emerging Diseases and Bioterrorism (Editor: Torrence PF) Wiley & Sons, Hoboken, NJ. 2005; pp.379-395.
Selected Publications
  1. Wang D, Shanina I, Toyofuku WM, Horwitz MS, Scott MD:  Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy.  PlosONE, 2015; In Press.
  2. Wang D, Toyofuku WM, Chen AM, Scott MD: Induction of immunotolerance via mPEG grafting to allogeneic leukocytes. Biomaterials 2011; 32:9494-9503.

Leadership Roles

 

Click to see Leadership Roles:
2011 - CurrentMember, Scientific Advisory Board, LightIntegra Technologies
2007 - 2013Associate Director for Intellectual Property and Business Development, Canadian Blood Services
Book your donation